<DOC>
	<DOCNO>NCT00731289</DOCNO>
	<brief_summary>The aim study analyse difference functional clinical outcome intraarticular treatment patient osteoarthritis knee single injection hyaluronan ( HA ) Triamcinolone ( TA ) respect quality life study period .</brief_summary>
	<brief_title>Gait Patterns After Intraarticular Treatment Patients With Osteoarthritis Knee</brief_title>
	<detailed_description>Osteoarthritis ( OA ) common chronic joint disease age patient . The primarily affected joint knee hip . The progress disease important influence patient´s life , include functional social activity , body image emotional well . Furthermore , socioeconomic aspect play eminent role treatment osteoarthritis joint . In non-operative treatment , pain reduction improve function primary goal . It important distinguish systemic local therapeutic option . In systemic treatment , palliation pain achieve simple analgetics , non- steroidal anti-inflammatory drug opioids . Local therapy selectively treat symptomatic joint . Intraarticular application different drug injection perform . Glucocorticoids commonly use intraarticular agent , reduce pain improve function well . In recent year , intraarticular use different hyaluronan ( HA ) product become widely accept . Hyaluronan physiological component synovial fluid cartilage matrix . It responsible viscoelastic property synovial fluid . In osteoarthrotic joint , molecular weight concentration endogenous HA decrease compare healthy joint . This imply reduction viscoelasticity synovial fluid . In order restore viscoelasticity , augment flow synovial fluid , normalise synthesis inhibit degradation endogenous hyaluronan , application exogenous HA perform . The therapeutic effect safety intraarticular application HA treatment OA knee demonstrate several clinical trial . Until three study objectively analysed aspect functional outcome treatment HA .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>men woman 35 80 year age radiographically verify degenerative osteoarthritis knee ( grade II III accord Kellgren Lawrence classification ) pain least 40 mm 100 mm visual analogue scale ( VAS ) initial examination persist pain least 6 month LequesneScore least 10 point good physical mental status good compliance agreement participate study nondegeneratively induce osteoarthritis rheumatoid arthritis ligamentous instability complete resection meniscus Sudeck´s disease operation affect knee within last three month varus valgus deformity 15 degree patellofemoral arthritis intraarticular therapy affect joint within last 6 month hyaluronan three month glucocorticoid severe systemic disease ( tumor , exacerbate diabetes mellitus , hyperthyroidism ) antithrombotic medication regular medication NSAID/psychiatric pharmaceutical infectious disease alcohol abuse drug psychiatric disease suicidal tendency involvement another study noncompliance acute hemarthrosis joint effusion allergic predisposition skin infection skin disease around knee</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>Hyaluronan</keyword>
	<keyword>Gait Analysis</keyword>
</DOC>